Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2022-05-23
- Lead Sponsor
- Guy Waddell
- Target Recruit Count
- 60
- Registration Number
- NCT02449161
- Locations
- 🇨🇦
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
News
No news found